Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study
Titel:
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study
Auteur:
McAllister, Peter Winner, Paul K. Ailani, Jessica Buse, Dawn C. Lipton, Richard B. Chakhava, George Josiassen, Mette Krog Lindsten, Annika Mehta, Lahar Ettrup, Anders Cady, Roger